Monday, Sep 28, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle

"icmr"

  • ‘Covaxin a 2-dose anti-coronavirus vaccine, Anil Vij got only 1st dose’

    The 67-year-old minister was given the first shot on November 20.
  • Haryana Minister tests COVID positive weeks after getting trial dose of vaccine

    The 67-year-old is a senior leader of the ruling Bharatiya Janata Party (BJP) and a legislator from Ambala Cantt assembly constituency.
  • COVID-19 caseload in India rises to 95.71 lakh

    The number of people who have recuperated from the disease surged to 90,16,289 pushing the national recovery rate to 94.20 per cent.
  • COVID-19 caseload in India breaches 95-lakh mark

    The number of people who have recuperated from the disease surged to 89,73,373 pushing the national recovery rate to 94.11 per cent.
  • COVID-19 caseload in India climbs to 94.99 lakh

    The number of people who have recuperated from the disease surged to 89,32,647 pushing the national recovery rate to 94.03 per cent.
  • PM Modi visits Bharat Biotech facility in Genome valley

    Takes stock of the progress made by the Hyderabad-based company in the trials of Covaxin, jointly developed with ICMR-National Institute of Virology
  • PM Modi conducts whirlwind visit to Hyderabad

    He was received by Chief Secretary Somesh Kumar, DGP M Mahender Reddy and three other officials on behalf of the State government.
  • PM Modi reaches Hyderabad to visit Bharat Biotech plant

    He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the Air Force base, officials said.
  • COVID-19 caseload in India climbs to 93,09,787

    There are 4,55,555 active cases of coronavirus infection in the country which comprises 4.89 per cent of the total caseload.
  • Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

    The Hyderabad-based firm, while applying for phase-three trial, stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.
  • India’s COVID-19 tally reaches 92.66 lakh, recoveries surge to 86.79 lakh

    The total number of people who have recuperated from the disease surged to 86,79,138, pushing the national recovery rate to  93.66 per cent.
  • India’s COVID-19 caseload goes past 92 lakh

    The number of people who have recuperated from the disease surged to 86,42,771, pushing the national recovery rate to 93.72 per cent.
  • India reports 44,059 new COVID-19 cases, 511 deaths in last 24 hours

    Maharashtra has 80,878 active coronavirus cases, the highest in the country, followed by Kerala with 66,982 and Delhi with 39,741.
  • 13 cr COVID-19 tests done so far, cumulative positivity rate falling steadily: Health Ministry

    New Delhi:  The total number of tests conducted in India for the detection of COVID-19 infection has crossed the 13-crore mark with last one crore done in just 10 days, while the cumulative positivity rate remained low and continues a downward trajectory, the Union Health Ministry said on Saturday. According to the Indian Council of […]
  • COVID-19 caseload in India breaches 90-lakh mark

    There are 4,43,794 active cases of coronavirus infection in the country which comprises 4.92 per cent of the total caseload.
  • Covid vaccine by 2021 July-August: Harsh Vardhan

    Healthcare workers, people above 65 yrs will be given COVID vaccine on priority, says Union Health Minister
  • COVID-19: India records 45,576 infections, 585 fatalities

    There are 4,43,303 active cases of coronavirus infection in the country as on date which accounts for 4.95 per cent of the total caseload.
  • Phase 3 trial of Covaxin to begin in Haryana on Nov 20

    Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.
  • Indiscriminate use of plasma therapy not good: ICMR

    CPT did not lead to reduction in progression to severe Covid-19 or all-cause mortality in the group that received CPT as compared to the group that did not receive the therapy, said ICMR study
  • Hyderabad-based Bharat Biotech starts phase III trials for Covaxin

    The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR
« 1 … 5 6 7 8 »

Latest News

  • Election Commission row: Kishan Reddy slams Congress over EVM allegations

    17 seconds ago
  • Village, ward secretariat staff scuffle with police during Chalo Vijayawada protest

    14 minutes ago
  • Editorial: Shrinking rural jobs a bitter reality

    28 minutes ago
  • Bank unions defer nationwide strike after IBA assurance; banks to open Monday

    38 minutes ago
  • Gujarat police files FIR over alleged Rs 1,143 crore political donation racket

    47 minutes ago
  • Hyderabad police nab youth for circulating fake Rs 500 notes

    1 hour ago
  • Students clash with Punjab police, vehicles torched at LPU over alleged rape, suicide

    1 hour ago
  • Owaisi urges citizens to respond to SIR notices, warns SIR of electoral rolls could be NRC backdoor

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App